ABBV
55
-4
NTRS
39
2
GME
71
3
R
70
5
AVGO
15
2
NRG
55
-7
DUK
62
-2
PH
67
5
SNA
52
3
JBHT
42
4
IFF
44
5
DLTR
50
2
CAT
44
2
IBM
55
-2
OKE
73
5
IVZ
42
6
CSCO
69
8
CHD
53
-3
MSI
60
2
MO
62
-7
ABBV
55
-4
NTRS
39
2
GME
71
3
R
70
5
AVGO
15
2
NRG
55
-7
DUK
62
-2
PH
67
5
SNA
52
3
JBHT
42
4
IFF
44
5
DLTR
50
2
CAT
44
2
IBM
55
-2
OKE
73
5
IVZ
42
6
CSCO
69
8
CHD
53
-3
MSI
60
2
MO
62
-7
Financhill
Back

Jumia Technologies AG Vs. Sarepta Therapeutics Industry Stock Comparison

Sell
23

JMIA
Jumia Technologies AG

Last Price:
$1.98
Seasonality Move:
17.06%
Sell
50

SRPT
Sarepta Therapeutics

Last Price:
$58.64
Seasonality Move:
15.14%
Sell
23
Jumia Technologies AG (JMIA) is a Sell

Is Jumia Technologies AG a Buy, Sell or Hold?

  • The current Jumia Technologies AG [JMIA] share price is $2.20. The Score for JMIA is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
  • JMIA is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
50
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $62.47. The Score for SRPT is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

JMIA Stock Price Chart

What is Jumia Technologies AG's stock price today?

  • The Jumia Technologies AG share price today is $2.20
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and JMIA is experiencing slight buying pressure.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $62.47
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing slight buying pressure.

JMIA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.23 Sell
Relative Strength Index (14 RSI): 34.89 Sell
Chaikin Money Flow: 228800 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.27 - 2.49) Sell
Bollinger Bands (100): (2.81 - 4.37) Sell

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -11.2 Sell
Relative Strength Index (14 RSI): 23.74 Sell
Chaikin Money Flow: 16191 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (71.23 - 103.89) Sell
Bollinger Bands (100): (93.83 - 127.79) Sell

JMIA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 2.32 Sell
20-day SMA: 2.37 Sell
50-day SMA: 3.11 Sell
200-day SMA: 5.28 Sell
8-day EMA: 2.28 Sell
20-day EMA: 2.45 Sell
50-day EMA: 2.94 Sell
200-day EMA: 4.29 Sell

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 69.16 Sell
20-day SMA: 83.4 Sell
50-day SMA: 100.16 Sell
200-day SMA: 123.02 Sell
8-day EMA: 68.84 Sell
20-day EMA: 80.01 Sell
50-day EMA: 95.17 Sell
200-day EMA: 114.59 Sell

Jumia Technologies AG Earnings Growth & JMIA Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.40 per share, and a decrease next year of $0.00 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.52 per share, a decrease next quarter of $0.64 per share, an increase this year of $5.33 per share, and an increase next year of $5.23 per share.

Jumia Technologies AG Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):